| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone sodium phosphate 10mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 5mg/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 0.1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha 4mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha 0.1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha 0.05% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone phosphate + dexamethasone sodium phospha 1mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha + lidocaine hydrochloride 0ns/10mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha + neomycin sulphate 0ns/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + neomycin sulphate 1mg/3.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone sodium phosphate and neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 0.05% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 24mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha 10mg injection solution vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 4mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 0.05% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone (as dexamethasone sodium phosphate) 400 microgram/mL oral solution |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and tobramycin (as tobramycin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]